Showing results (31-40 of 154) with videos related to
Sort By:
Pageof 16
Clinical Neurology and Neurosurgery|January 18, 2006
Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon betaCavit Boz, Mehmet Ozmenoglu, Sibel Velioglu, et al.Journal of Neurology|December 25, 2012
Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: a multicenter studyGerardo Iuliano, Cavit Boz, Edgardo Cristiano, et al.Journal of Clinical Neurology (Seoul, Korea)|October 18, 2014
Evaluation of temperament and character features as risk factors for depressive symptoms in patients with restless legs syndromeVildan Altunayoglu Cakmak, Sibel Gazioglu, Nuray Can Usta, et al.Clinical Neurology and Neurosurgery|August 10, 2020
Methylprednisolone Concentrations in Breast Milk and Serum of Patients with Multiple Sclerosis Treated with IV Pulse MethylprednisoloneSerap Zengin Karahan, Cavit Boz, Murat Terzi, et al.Archives of Neurology|June 14, 2006
Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomyIlya Kister, Sandeep Gulati, Cavit Boz, et al.Multiple Sclerosis International|March 12, 2016
Lack of Association between Pulse Steroid Therapy and Bone Mineral Density in Patients with Multiple SclerosisSerap Zengin Karahan, Cavit Boz, Sevgi Kilic, et al.Neurological Research|January 22, 2023
Clinical course and outcome of Covid-19 in patients with myasthenia gravisGonulden Aktoz, Cavit Boz, Serap Zengin, et al.Journal of Acupuncture and Meridian Studies|April 5, 2019
The Efficacy of Acupuncture in the Treatment of Bell's Palsy SequelaeCanan Ertemoğlu Öksüz, Ahmet Kalaycıoğlu, Özlem Uzun, et al.Functional Neurology|December 15, 2004
The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center studyF Cankat Tulunay, Hakan Ergün, Sinem Ezgi Gülmez, et al.Multiple Sclerosis and Related Disorders|April 30, 2026
Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivityIpek Gungor Dogan, Sedat Sen, Damla Cetinkaya Tezer, et al.Pageof 16